SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Danimer Scientific, Inc. (DNMR) , 前瞻盈利收益率 1,666.67%.
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+157.1%).
- 前瞻市盈率 0.1
- 分析师共识目标价 $0.90 (+157.1% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 38/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
75/100
Debt-to-Equity & liquidity
→ Health
估值概览 — DNMR
估值倍数
P/E (TTM)0.0
前瞻 P/E0.1
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.76
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.52
前瞻 EPS（预估）$6.00
每股账面价值$0.00
每股营收$0.46
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield1,666.67%
股息收益率0.00%
分析师目标价$0.90 (+157.1%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2018 |
$0.07 |
$30.45M |
$208K |
0.7% |
| 2019 |
$-0.77 |
$32.34M |
$-19.51M |
-60.3% |
| 2020 |
$-0.18 |
$47.33M |
$-14.97M |
-31.6% |
| 2021 |
$-0.65 |
$58.75M |
$-60.11M |
-102.3% |
| 2022 |
$-1.78 |
$53.22M |
$-179.76M |
-337.8% |
| 2023 |
$-1.52 |
$46.68M |
$-155.47M |
-333% |
